Myriad Genetics (MYGN) 10-K2003 FY Annual report

Filed: 22 Sep 03, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: accelerated, accomplish, adequacy, ADME, antiviral, arrive, Australia, bad, breach, budding, charter, civil, clearinghouse, Committee, content, conventional, criminal, deadline, Diego, discourage, disproportionate, dominant, doubtful, electronic, electronically, elucidate, embedded, enroll, enrolled, enrollment, enterprise, enzyme, Europe, exhausted, filer, fill, framework, gap, HHS, HIPAA, hit, hormone, hostile, inactive, inconclusive, inconvenient, insight, interim, intervention, invoiced, IV, journalCell, length, loan, margin, metastatic, methodology, mild, mimetic, moderate, Morgan, negative, nonrenewal, observing, oral, parent, passed, pending, peptide, pharmacokinetic, poison, Portability, prevalent, privacy, proportional, prove, proximity, purpose, recall, recovery, recurrence, redone, refusal, remedial, remediate, remote, repeat, repeated, residual, revised, RNA, San, satisfactorily, Simplification, simplifying, specialty, staggered, Stanley, sterile, stringent, suspension, team, textual, toxicology, transmission, twelve, underwritten, undetected, variable, version, viability, violation, waiting, Wakara, watchful, web, written, Zealand

Removed: achieved, Acqua, agent, Agricultural, AGT, alliance, Annex, announced, arising, biochemistry, biology, Biotech, blood, built, capture, central, cGMP, chemoprevention, chronic, Clinton, codified, commonly, complement, concerted, detected, diet, dietary, disclosed, disposition, DNA, dramatically, easily, easy, established, exploring, extend, extracted, extremely, fund, fundamental, generate, genetically, granting, grew, highest, hypertensive, increasing, inexpensive, inflammatory, Institute, Intermountain, introducing, locate, maintaining, mammalian, manipulated, Modernization, Monsanto, mortality, mutant, nonexclusive, North, obstructive, offer, optimizing, pain, personalized, potentially, predisposed, president, produced, PSA, pulmonary, receipt, reduction, reimbursed, released, retiring, rheumatoid, saving, selecting, sequence, showed, sleep, strain, stroke, subsidiary, unknown, unproductive, Valley, variant, vast, Wellington, withdrawal, yeast

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

MYGN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

Consent of Independent Auditors

The Board of Directors

Myriad Genetics, Inc.

We consent to incorporation by reference in the registration statements (No.’s 33-99204, 333-04700, 333-23255, 333-40961, 333-93363 and 333-72978) on Forms S-8, and in the registration statements (No.’s 333-73124, 333-45772 and 333-50504) on Forms S-3 of Myriad Genetics, Inc. of our report dated August 25, 2003, related to the consolidated balance sheets of Myriad Genetics, Inc. and subsidiaries as of June 30, 2003 and 2002 and the related consolidated statements of operations, stockholders’ equity and comprehensive loss and cash flows for each of the years in the three-year period ended June 30, 2003, and related schedule, which report appears in the June 30, 2003 annual report on Form 10-K of Myriad Genetics, Inc.

KPMG LLP

Salt Lake City, Utah

September 17, 2003